Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Bramanti

Checkpoint Inhibition Before Haploidentical Transplantation in Relapsed or Refractory Hodgkin Lymphoma Patients Is Associated With Higher PFS Without Increased Toxicities

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Impact of Class Ii Hla Mismatch on Clinical Outcomes in Hodgkin Lymphoma Patients Receiving Haploidentical Stem Cell Transplantation (Haplo-Sct) With Post-Transplant Cyclophosphamide (Pt-Cy)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Related publications

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Pulmonary Toxicity in Paediatric Patients With Relapsed or Refractory Hodgkin Lymphoma Receiving Brentuximab Vedotin

British Journal of Haematology
Hematology
2018English

Combination of Nivolumab and Bendamustine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Tandem Autologous-Haploidentical Transplantation Is a Feasible and Effective Program for Refractory Hodgkin Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2017English

Potentially Inappropriate Medication Use in Elderly Non-Hodgkin Lymphoma Patients Is Associated With Reduced Survival and Increased Toxicities

British Journal of Haematology
Hematology
2017English

Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated With PD1 Inhibition

British Journal of Haematology
Hematology
2017English

Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey

Annals of Hematology
MedicineHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy